Abstract:Mammalian adipose tissue can be divided into two major types, namely, white adipose tissue (WAT) and brown adipose tissue (BAT). According to classical view, the main function of WAT is to store excess energy in the form of triglycerides, while BAT is a thermogenic tissue that acts a pivotal part in maintaining the core body temperature. White adipocytes display high plasticity and can transdifferentiate into beige adipocytes which have many similar morphological and functional properties with brown adipocytes under the stimulations of exercise, cold exposure and other factors. This phenomenon is also known as 'browning of WAT'. In addition to transdifferentiation, beige adipocytes can also come from de novo differentiation from tissue-resident progenitors. Activating BAT and inducing browning of WAT can accelerate the intake of glycolipids and reduce the insulin secretion requirement, which may be a new strategy to improve glycolipids metabolism and insulin resistance of obese and type 2 diabetes mellitus (T2DM) patients. This review mainly discusses the significance of brown and beige adipose tissues in the treatment of obesity and T2DM, and focuses on the effect of the browning agent on obesity and T2DM, which provides a brand-new theoretical reference for the prevention and treatment of obesity and T2DM.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are new treatment methods for obesity and type 2 diabetes mellitus (T2DM). Specifically, the author explored the potential of brown adipose tissue (BAT) and beige adipose tissue in treating these two diseases. The following is a detailed interpretation: ### Main problems in the paper 1. **The current situation and challenges of obesity and type 2 diabetes mellitus**: - The global obesity rate continues to rise. There are approximately 2.2 billion people who are overweight, among which 712 million are obese. - Obesity affects insulin sensitivity, which in turn affects systemic glucose homeostasis and leads to multiple diseases, such as insulin resistance and type 2 diabetes mellitus (T2DM). - Although there are many methods for treating obesity and T2DM, including drugs, lifestyle interventions, etc., these methods have side effects or limited efficacy. 2. **The role of brown adipose tissue (BAT) and beige adipose tissue**: - The main function of brown adipose tissue (BAT) is to consume energy through thermogenesis and maintain core body temperature. - Beige adipocytes can be generated in white adipose tissue (WAT) through the "white - to - brown fat conversion" process and have functions similar to brown adipocytes. - Activating BAT and inducing the browning of WAT can accelerate glycolipid metabolism, reduce the need for insulin secretion, and thus improve glycolipid metabolism and insulin resistance in patients with obesity and T2DM. 3. **New treatment strategies**: - By activating brown adipose tissue and inducing the browning of white adipose tissue, a new strategy for treating obesity and T2DM is provided. - The effects of factors such as exercise, cold exposure, brown fat transplantation, gut microbiota, intermittent fasting, and calorie restriction on BAT and beige adipose tissue were explored. ### Key mechanisms - **Activating brown adipose tissue (BAT)**: BAT increases energy consumption through β - oxidation of fatty acids and glucose uptake, improving insulin sensitivity and blood - glucose levels. - **Inducing the browning of white adipose tissue (WAT)**: Through external stimuli (such as cold exposure, β3 - adrenergic receptor agonists, etc.), beige adipocytes in WAT accelerate the absorption of circulating glucose and lipids, increasing energy consumption and thermogenesis. - **The role of non - coding RNA (ncRNA)**: miRNAs play a bidirectional role in activating brown and beige adipose tissues, regulating gene expression, and affecting adipocyte differentiation and function. ### Conclusion This paper aims to emphasize the potential of brown adipose tissue and beige adipose tissue in treating obesity and type 2 diabetes mellitus, and explores a variety of possible intervention measures, providing a theoretical basis for future research and clinical applications.

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans

Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism

An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications

An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications

Plasticity of Adipose Tissues: Interconversion among White, Brown, and Beige Fat and Its Role in Energy Homeostasis

Brown and Beige Fat： the Metabolic Function, Induction, and Therapeutic Potential

Econutrition, Brown And Beige Fat Tissue And Obesity

Natural Bioactive Compounds as Potential Browning Agents in White Adipose Tissue

Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia

Many Ways to Rome: Exercise, Cold Exposure and Diet—Do They All Affect BAT Activation and WAT Browning in the Same Manner?

Natural bioactive constituents from herbs and nutraceuticals promote browning of white adipose tissue

New Regulators of Lipid Metabolism

Brown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity

Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues

Brown and beige fat: development, function and therapeutic potential

Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis

Weighing in on the role of brown adipose tissue for treatment of obesity

Browning of Adipocytes: A Potential Therapeutic Approach to Obesity

Nutritional Regulation of Human Brown Adipose Tissue